News SMC approves medicines for breast cancer, skin cancer, schiz... The Scottish Medicines Consortium (SM
Views & Analysis Keeping up the PACE at the Scottish Medicines Consortium (SM... There are many ways that patient centricity could be delivered when doing a health technology assessment (HTA).
Views & Analysis The shadow of Brexit on speed of access No-one can miss the ongoing saga that is the UK’s exit from the European Union (EU).
News Scotland says no to Yescarta, but backs Kymriah Scotland’s cost-effectiveness watchdog has decided against making Gilead’s CAR-T therapy Yescarta routinely available to patients with two types of lymphoma, but gave a green light to Novar
Views & Analysis Access to new medicines in Scotland: a perennial issue Access to new medicines in Scotland – just as it would seem is the case everywhere – is always on the agenda.
Oncology Closing the global evidence gap in oncology, with Flatiron H... Kate Estep discusses Flatiron’s AI-powered oncology intelligence platform, Telescope, and how AI tools are changing research decisions.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
